| Quality Matters | U.S. Pharmacopeia Blog

One Meeting. Hundreds of Global Healthcare Professionals. A World of Difference.

USP Staff Submitted by USP Staff on Tue, 05/19/2015 - 10:00
Global Healthcare Professionals Convention

The 2015 USP Convention is over, but the theme of the meeting - 'Shoulder to Shoulder on the Path to Improve Global Health' - will continue to be echoed over the next five years. Indeed, many of those who attended didn't just make connections, they listened, engaged and sought collaborations that may truly make a world of difference.

Prevent Medication Dosing Errors – Ditch the Teaspoon

Will Whitaker Submitted by Will Whitaker on Tue, 05/12/2015 - 07:00
Prevent medication errors - avoid the teaspoon

Over and under dosing--especially of children--based upon the “teaspoon” dosing instruction, can prolong an illness, compound an existing ailment, and may lead to death. USP has joined a growing chorus of public health organizations and government agencies calling for an end to the teaspoon as a unit of medication dosage measurement.

Elemental Impurities – Their Impact on Drug Quality

Kahkashan Zaidi Submitted by Kahkashan Zaidi on Wed, 05/06/2015 - 15:41
While manufacturers have to ensure the quality and consistency of ingredients that go into a final pharmaceutical product, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.

Today, approximately 80% of all active pharmaceutical ingredients in medicines sold in the U.S. are manufactured in another part of the world. While manufacturers have to ensure the quality and consistency of ingredients that go into final pharmaceutical products, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.

Retiring USP Chief Science Officer Reflects on 29-year Career Improving Global Public Health

USP Staff Submitted by USP Staff on Tue, 04/28/2015 - 07:00
USP Chief Science Officer Retires

Dr. V. Srini Srinivasan, Executive Vice President and Chief Science Officer, is retiring after 29 years at the United States Pharmacopeia, where he provided leadership for documentary standard setting activities for all of USP’s compendia while overseeing the organization’s global expansion to India, China and Brazil.